Propiedad y actividad de insiders de PDS Biotechnology Corporation (PDSB): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.99 |
| Capitalización | $55M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-01-12 | BEDU-ADDO FRANK | A-Award | 548,782 | $538K |
| 2026-01-12 | CONN GREGORY | A-Award | 150,000 | $147K |
| 2026-01-12 | Shepard Kirk V. | A-Award | 300,000 | $294K |
| 2026-01-12 | Boesgaard Lars | A-Award | 300,000 | $294K |
| 2026-01-12 | Brown Spencer D. | A-Award | 300,000 | $294K |
| 2026-01-12 | Toutain Stephan | A-Award | 300,000 | $294K |
| 2026-01-12 | Freitag Gregory Gene | A-Award | 54,876 | $54K |
| 2026-01-12 | Iliev Ilian | A-Award | 54,876 | $54K |
| 2026-01-12 | Ali-Jackson Kamil | A-Award | 54,876 | $54K |
| 2026-01-12 | BRAWLEY OTIS W | A-Award | 54,876 | $54K |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $106.4M | $88.1M | $34.6M | $12.2M | $28.8M | $65.2M | $73.8M | $56.6M | $41.7M | $26.7M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $107.4M | $89.1M | $35.7M | $14.5M | $30.3M | $66.8M | $76.5M | $59.1M | $45.1M | $28.3M |
| Inmovilizado Material | $3.4M | $3.4M | $426952 | $21051 | $553149 | $357697 | $527533 | $335005 | $304214 | $243698 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $51918 | $46805 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $110.9M | $92.6M | $36.2M | $14.5M | $30.9M | $67.2M | $77.0M | $59.4M | $45.4M | $30.5M |
| Cuentas por Pagar | $3.5M | $4.4M | $399447 | $1.2M | $1.4M | $1.3M | $1.2M | $7.0M | $1.7M | $3.6M |
| Deuda a Corto | 0 | $3.1M | 0 | 0 | 0 | 0 | 0 | $4.2M | $12.5M | $5.1M |
| Pasivos Corrientes | $6.7M | $12.9M | $6.4M | $2.8M | $3.3M | $3.8M | $9.8M | $13.6M | $17.1M | $9.5M |
| Deuda a Largo | $15.0M | $17.4M | $30000 | 0 | 0 | 0 | $23.0M | $19.5M | $9.2M | $11.7M |
| Pasivos Totales | $21.6M | $30.2M | $6.4M | $2.8M | $3.8M | $4.0M | $33.0M | $33.3M | $26.4M | $21.2M |
| Reservas | -$101.1M | -$151.9M | -$192.8M | -$28.9M | -$43.8M | -$60.7M | -$101.6M | -$144.5M | -$182.1M | -$216.6M |
| Patrimonio Neto | $89.3M | $62.4M | $29.8M | $11.7M | $27.1M | $63.2M | $44.0M | $26.1M | $19.0M | $9.3M |
| Deuda Total | $15.0M | $20.5M | $30000 | 0 | $610257 | $490354 | $23.5M | $23.9M | $21.8M | $16.9M |
| Deuda Neta | -$91.4M | -$67.6M | -$34.6M | -$12.2M | -$28.2M | -$64.8M | -$50.3M | -$32.7M | -$19.9M | -$9.8M |
| Capital Circulante | $100.7M | $76.2M | $29.3M | $11.7M | $27.1M | $63.1M | $66.7M | $45.4M | $28.0M | $18.8M |
Salud financiera
| Deuda / Patrimonio | -1.22 |
| Ratio corriente | 0.57 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -11.61 |
Rentabilidad
| Rentabilidad sobre capital | -708.20% |
| Rentabilidad sobre capital invertido | -3550.39% |
| Rentabilidad sobre activos | -382.32% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ANVS · ATNM · FGEN · INMB · KZR · LVTX · OKUR
Explorar sector: Healthcare · Biotechnology
Más secciones de PDSB: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones